Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia.

Literature DB >> 20930122

Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia.

Iria Vázquez, Miren Maicas, Nerea Marcotegui, Ana Conchillo, Elisabet Guruceaga, José Roman-Gomez, María J Calasanz, Xabier Agirre, Felipe Prosper, María D Odero.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20930122 PMCID： PMC2973895 DOI： 10.1073/pnas.1011540107

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

4 in total

1. Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome.

Authors: Jerome Dickstein; Vitalyi Senyuk; Kavitha Premanand; Leopoldo Laricchia-Robbio; Peng Xu; Francesca Cattaneo; Raffaella Fazzina; Giuseppina Nucifora
Journal: Proc Natl Acad Sci U S A Date: 2010-05-06 Impact factor: 11.205

Review 2. EVI1 and hematopoietic disorders: history and perspectives.

Authors: Giuseppina Nucifora; Leopoldo Laricchia-Robbio; Vitalyi Senyuk
Journal: Gene Date: 2005-11-28 Impact factor: 3.688

3. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.

Authors: Xabier Agirre; Amaia Vilas-Zornoza; Antonio Jiménez-Velasco; José Ignacio Martin-Subero; Lucia Cordeu; Leire Gárate; Edurne San José-Eneriz; Gloria Abizanda; Paula Rodríguez-Otero; Puri Fortes; José Rifón; Eva Bandrés; María José Calasanz; Vanesa Martín; Anabel Heiniger; Antonio Torres; Reiner Siebert; José Román-Gomez; Felipe Prósper
Journal: Cancer Res Date: 2009-05-12 Impact factor: 12.701

Review 4. The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions.

Authors: Rotraud Wieser
Journal: Gene Date: 2007-04-20 Impact factor: 3.688

4 in total

15 in total

1. Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis.

Authors: Yanhong Zhao; Xuefang Zhang; Yanqiu Zhao; Desheng Kong; Fan Qin; Jing Sun; Ying Dong
Journal: Med Oncol Date: 2015-04-02 Impact factor: 3.064

2. MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer.

Authors: Liming Xie; Zhiwei Zhang; Zhiqin Tan; Rongfang He; Xi Zeng; Yuanjie Xie; Suyun Li; Guohua Tang; Hailin Tang; Xiusheng He
Journal: Mol Cell Biochem Date: 2014-07 Impact factor: 3.396

3. miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src.

Authors: Xu-Bao Shi; Ai-Hong Ma; Lingru Xue; Meimei Li; Hao G Nguyen; Joy C Yang; Clifford G Tepper; Regina Gandour-Edwards; Christopher P Evans; Hsing-Jien Kung; Ralph W deVere White
Journal: Cancer Res Date: 2015-11-16 Impact factor: 12.701

Review 4. MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemia.

Authors: Su Jung Song; Pier Paolo Pandolfi
Journal: Curr Opin Hematol Date: 2014-07 Impact factor: 3.284

5. miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1.

Authors: Yu-Shui Ma; Fei Yu; Xiao-Ming Zhong; Gai-Xia Lu; Xian-Ling Cong; Shao-Bo Xue; Wen-Ting Xie; Li-Kun Hou; Li-Juan Pang; Wei Wu; Wei Zhang; Le-Le Cong; Tie Liu; Hui-Deng Long; Ran Sun; Hong-Yan Sun; Zhong-Wei Lv; Chun-Yan Wu; Da Fu
Journal: Mol Ther Date: 2018-09-13 Impact factor: 11.454

Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia.

1. Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome.

Review 2. EVI1 and hematopoietic disorders: history and perspectives.

3. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.

Review 4. The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions.

1. Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis.

2. MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer.

3. miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src.

Review 4. MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemia.

5. miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1.

6. EVI1 splice variants modulate functional responses in ovarian cancer cells.

Review 7. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer.

8. MicroRNA miR124 is required for the expression of homeostatic synaptic plasticity.

Review 9. Noncoding RNAs in Acute Myeloid Leukemia: From Key Regulators to Clinical Players.

10. The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.